Search Results

QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.

Oklahoma’s bioscience community is announcing a relaunch of its industry association, with the new Life Science Oklahoma bringing new leadership, a new format and renewed focus and support to businesses and organizations within the Oklahoma life sciences and healthcare communities.

ViewRay, Inc. announced that the VA Oklahoma City Healthcare System has selected MRIdian MRI-guided radiation therapy system to expand radiation therapy services at the Oklahoma City VA Medical Center.

Toronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), announces today the launch of an additional Licensing Partnership agreement in North America.

The University of Oklahoma has received funding from the National Institutes of Health to establish the Oklahoma Center of Medical Imaging for Translational Cancer Research.

RenovoRx, Inc today announced the expansion of their clinical development pipeline in preparation for the commencement of a second Phase III trial.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Oklahoma Biotech Startup Programs, or OKBioStart, is one of the six initiatives that make up the Oklahoma Biotech Innovation Cluster sharing in a $35 million award from the U.S. Economic Development Association’s Build Back Better Regional Challenge.